Harbin Medisan Pharmaceutical Co., Ltd.
SZSE:002900.SZ
12.44 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2015 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 315.082 | 273.793 | 243.787 | 264.327 | 285.233 | 295.078 | 342.148 | 266.525 | 257.147 | 248.046 | 256.694 | 238.136 | 233.828 | 243.656 | 230.179 | 372.42 | 339.293 | 338.375 | 288.796 | 470.934 | 504.708 | 625.721 | 500.698 | 596.926 | 580.15 | 523.02 | 472.421 | 481.08 | 285.8 | 211.552 | 170.399 | 226.87 | 183.732 | 166.449 |
| Cost of Revenue
| 169.735 | 144.283 | 105.982 | 129.168 | 124.719 | 95.084 | 127.408 | 92.773 | 81.685 | 81.408 | 104.471 | 81.396 | 68.692 | 76.01 | 83.286 | 154.011 | 128.144 | 102.981 | 106.164 | 158.546 | 124.668 | 124.294 | 102.414 | 101.478 | 92.74 | 81.39 | 76.36 | 88.33 | 65.673 | 66.957 | 75.741 | 89.245 | 63.772 | 62.657 |
| Gross Profit
| 145.347 | 129.51 | 137.805 | 135.159 | 160.514 | 199.993 | 214.739 | 173.752 | 175.462 | 166.639 | 152.223 | 156.74 | 165.136 | 167.645 | 146.893 | 218.408 | 211.149 | 235.393 | 182.632 | 312.388 | 380.041 | 501.426 | 398.284 | 495.448 | 487.41 | 441.629 | 396.061 | 392.75 | 220.127 | 144.594 | 94.658 | 137.625 | 119.96 | 103.792 |
| Gross Profit Ratio
| 0.461 | 0.473 | 0.565 | 0.511 | 0.563 | 0.678 | 0.628 | 0.652 | 0.682 | 0.672 | 0.593 | 0.658 | 0.706 | 0.688 | 0.638 | 0.586 | 0.622 | 0.696 | 0.632 | 0.663 | 0.753 | 0.801 | 0.795 | 0.83 | 0.84 | 0.844 | 0.838 | 0.816 | 0.77 | 0.683 | 0.556 | 0.607 | 0.653 | 0.624 |
| Reseach & Development Expenses
| 27.377 | 20.941 | 24.692 | 35.049 | 25.885 | 31.643 | 20.229 | 25.765 | 26.17 | 21.37 | 15.964 | 29.223 | 22.226 | 26.35 | 22.123 | 31.537 | 25.256 | 34.393 | 20.833 | 49.543 | 20.541 | 21.373 | 20.992 | 18.327 | 20.33 | 62.274 | 18.431 | 84.274 | 24.084 | 30.347 | 0 | 49.036 | 0 | 13.077 |
| General & Administrative Expenses
| 72.721 | 14.724 | 39.162 | -88.104 | 65.919 | 24.686 | 34.17 | 41.758 | 56.161 | 8.065 | 28.398 | 4.186 | 56.219 | 13.079 | 27.709 | -16.306 | 28.148 | 7.324 | 36.797 | -4.146 | 32.329 | -22.256 | 33.277 | -51.857 | 22.75 | -30.748 | 37.906 | -88.021 | 43.116 | -27.303 | 31.537 | -80.489 | 37.565 | 28.229 |
| Selling & Marketing Expenses
| 98.916 | 67.693 | 80.76 | 59.926 | 95.281 | 122.357 | 144.232 | 99.617 | 125.571 | 117.636 | 111.086 | 165.605 | 121.598 | 125.353 | 105.017 | 152.705 | 155.786 | 179.01 | 117.565 | 194.368 | 270.727 | 377.945 | 310.579 | 395.595 | 390.667 | 339.026 | 310.781 | 287.682 | 107.483 | 41.457 | 29.357 | 37.367 | 32.344 | 20.581 |
| SG&A
| 171.637 | 102.124 | 119.936 | -28.178 | 161.2 | 147.044 | 178.402 | 149.012 | 181.732 | 125.701 | 139.484 | 169.791 | 177.817 | 138.432 | 132.726 | 136.399 | 183.934 | 186.334 | 154.362 | 190.222 | 303.055 | 355.689 | 343.856 | 343.738 | 413.417 | 308.279 | 348.687 | 199.66 | 150.599 | 14.154 | 60.894 | -43.122 | 69.909 | 48.81 |
| Other Expenses
| -71.72 | -0.797 | -0.318 | 1.507 | -0.088 | 0.9 | -6.999 | -15.837 | -26.733 | 23.032 | 2.652 | -1.542 | -8.571 | 8.157 | 0.006 | -2.025 | 0.178 | 0.011 | -0.271 | 2.923 | -3.548 | 0.004 | 0.035 | 0.093 | 0.014 | -1.993 | -0.012 | 0.377 | -0.009 | -0.038 | 0 | 7.336 | 3.166 | 0.668 |
| Operating Expenses
| 127.295 | 123.862 | 144.946 | 133.428 | 164.012 | 204.287 | 191.631 | 158.94 | 181.169 | 170.102 | 158.1 | 241.573 | 179.421 | 189.354 | 154.888 | 215.182 | 199.946 | 221.872 | 149.473 | 279.591 | 319.051 | 423.578 | 361.886 | 430.579 | 434.9 | 388.24 | 351.227 | 320.358 | 155.065 | 83.526 | 60.528 | 69.435 | 72.461 | 50.778 |
| Operating Income
| 18.052 | 5.648 | -7.141 | 16.282 | 6.27 | 13.17 | 43.3 | 14.813 | 10.427 | 8.876 | 3.924 | -95.432 | -48.622 | 34.632 | 564.228 | 3.968 | -5.971 | -2.553 | 39.821 | 28.526 | 53.32 | 79.535 | 67.429 | 22.925 | 46.729 | 104.043 | 77.3 | 68.972 | 61.646 | 88.899 | 33.191 | 64.517 | 46.513 | 66.952 |
| Operating Income Ratio
| 0.057 | 0.021 | -0.029 | 0.062 | 0.022 | 0.045 | 0.127 | 0.056 | 0.041 | 0.036 | 0.015 | -0.401 | -0.208 | 0.142 | 2.451 | 0.011 | -0.018 | -0.008 | 0.138 | 0.061 | 0.106 | 0.127 | 0.135 | 0.038 | 0.081 | 0.199 | 0.164 | 0.143 | 0.216 | 0.42 | 0.195 | 0.284 | 0.253 | 0.402 |
| Total Other Income Expenses Net
| 0.156 | -1.32 | 0.215 | 1.507 | -0.055 | 0.868 | 0.033 | -1.827 | 0.726 | 0.049 | 0.492 | -1.542 | -0.446 | 0.032 | 0.006 | -2.025 | 0.178 | 0.011 | -0.271 | 2.923 | -3.548 | 0.004 | 0.035 | 0.093 | 0.014 | -1.993 | -0.012 | 0.906 | -0.009 | -0.039 | 0 | 4.692 | 2.813 | 0.544 |
| Income Before Tax
| 18.208 | -5.792 | 12.304 | 17.788 | 6.214 | 14.038 | 43.333 | 12.986 | 2.873 | 26.443 | -2.232 | -96.974 | -49.068 | 34.664 | 564.234 | 1.943 | -5.793 | -2.542 | 39.549 | 31.449 | 49.772 | 79.54 | 67.463 | 23.018 | 46.742 | 102.05 | 77.287 | 69.877 | 61.465 | 88.503 | 33.192 | 67.209 | 49.325 | 67.496 |
| Income Before Tax Ratio
| 0.058 | -0.021 | 0.05 | 0.067 | 0.022 | 0.048 | 0.127 | 0.049 | 0.011 | 0.107 | -0.009 | -0.407 | -0.21 | 0.142 | 2.451 | 0.005 | -0.017 | -0.008 | 0.137 | 0.067 | 0.099 | 0.127 | 0.135 | 0.039 | 0.081 | 0.195 | 0.164 | 0.145 | 0.215 | 0.418 | 0.195 | 0.296 | 0.268 | 0.406 |
| Income Tax Expense
| 4.726 | -4.2 | 1.716 | 5.169 | -0.816 | 1.903 | 5.04 | 5.098 | 3.014 | 5.871 | -0.413 | 92.387 | -2.191 | 11.993 | 0.99 | -4.627 | 0.334 | 2.235 | 8.582 | 6.032 | 16.876 | 16.917 | 14.538 | -0.51 | 9.941 | 20.072 | 15.207 | 14.8 | 16.546 | 32.072 | 8.544 | 7.363 | 9.301 | 12.69 |
| Net Income
| 14.312 | 7.482 | 18.789 | 13.539 | 7.935 | 13.025 | 39.164 | 8.87 | -0.141 | 21.677 | -1.819 | -188.799 | -46.541 | 22.992 | 563.3 | 7.165 | -5.951 | -3.879 | 31.99 | 26.424 | 33.786 | 63.438 | 53.537 | 24.074 | 37.307 | 82.352 | 62.08 | 55.078 | 44.919 | 56.431 | 24.647 | 59.847 | 40.024 | 54.805 |
| Net Income Ratio
| 0.045 | 0.027 | 0.077 | 0.051 | 0.028 | 0.044 | 0.114 | 0.033 | -0.001 | 0.087 | -0.007 | -0.793 | -0.199 | 0.094 | 2.447 | 0.019 | -0.018 | -0.011 | 0.111 | 0.056 | 0.067 | 0.101 | 0.107 | 0.04 | 0.064 | 0.157 | 0.131 | 0.114 | 0.157 | 0.267 | 0.145 | 0.264 | 0.218 | 0.329 |
| EPS
| 0.05 | 0.024 | 0.059 | 0.07 | 0.026 | 0.042 | 0.12 | 0.03 | -0.001 | 0.07 | -0.006 | -0.61 | -0.15 | 0.073 | 1.78 | 0.024 | -0.02 | -0.013 | 0.1 | 0.086 | 0.11 | 0.2 | 0.17 | 0.071 | 0.11 | 0.26 | 0.29 | 0.17 | 0.19 | 0.24 | 0.11 | 0.25 | 0.17 | 0.23 |
| EPS Diluted
| 0.05 | 0.024 | 0.059 | 0.07 | 0.026 | 0.042 | 0.12 | 0.03 | -0 | 0.069 | -0.006 | -0.61 | -0.15 | 0.073 | 1.78 | 0.024 | -0.02 | -0.012 | 0.1 | 0.086 | 0.11 | 0.2 | 0.17 | 0.071 | 0.11 | 0.26 | 0.29 | 0.17 | 0.19 | 0.24 | 0.11 | 0.25 | 0.17 | 0.23 |
| EBITDA
| 25.842 | 31.024 | 47.96 | 23.687 | 32.321 | 38.201 | 68.977 | 6.631 | 21.969 | 50.163 | 21.513 | -74.008 | -10.951 | 618.948 | 566.587 | 31.615 | 14.753 | 17.185 | 64.415 | 57.454 | 73.971 | 102.052 | 89.244 | 78.351 | 67.08 | 92.85 | 44.834 | 101.105 | 67.777 | 90.447 | 34.13 | 75.614 | 47.499 | 53.014 |
| EBITDA Ratio
| 0.082 | 0.125 | 0.093 | 0.07 | 0.042 | 0.059 | 0.123 | 0.025 | 0.071 | 0.066 | 0.036 | -0.297 | -0.047 | -0.008 | 2.442 | 0.031 | 0.043 | 0.051 | 0.141 | 0.069 | 0.127 | 0.134 | 0.09 | 0.131 | 0.117 | 0.178 | 0.035 | 0.21 | 0.235 | 0.435 | 0.2 | 0.348 | 0.26 | 0.226 |